Exploratory Analysis of the Variable Response to an Intensive Lifestyle Change Program for Metabolic Syndrome

Author:

Maitland Scott B.1,Brauer Paula1,Mutch David M.1,Royall Dawna1,Klein Doug2,Tremblay Angelo3,Rheaume Caroline3,Jeejeebhoy Khursheed4

Affiliation:

1. University of Guelph

2. University of Alberta

3. Université Laval

4. University of Toronto

Abstract

Abstract Background Wide variability in response to lifestyle interventions has been recognized for many years, and researchers have begun to disentangle sources of error from inherent differences in individual responsiveness. The objective of this secondary analysis of an intensive lifestyle intervention (diet and exercise) for metabolic syndrome (MetS) was to identify potentially important differences among study completers grouped by treatment response as measured by change in a continuous metabolic syndrome (Gurka/MetS) score. Methods All study completers from a 12-month primary care study were categorized into one of five groups according to change in the Gurka/MetS score. A change of 0.4 in z-score defined clinically relevant change in line with results of previous studies. Repeated measures analysis of covariance was used to examine the Gurka/MetS score over 12 months, looking for differences in response over time by the five groups. Results Of 176 participants, 50% (n = 88) had stable scores, 10% (n = 18) had relevant change scores in the first 3 months only and reverted toward baseline, 20% (n = 35) achieved meaningful change over the whole study, 11% (n = 20) had a delayed response at 3–12 months, and 9% (n = 15) demonstrated worsening scores. Significant response group*time differences were noted (p < 0.001). Improvement in diet quality and fitness scores were similar across all groups. Available other variables did not account for the differences. Conclusion Work is needed to identify key factors that account for differences in responses to lifestyle interventions that can be used to guide treatment decisions for intensive lifestyle interventions for this common condition. Trial Registration ClinicalTrials.gov Identifier: NCT01616563; first registered June 12, 2012.

Publisher

Research Square Platform LLC

Reference53 articles.

1. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;GBD 2017 Risk Factor Collaborators;Lancet,2018

2. The Global Epidemic of the Metabolic Syndrome;Saklayen MG;Curr Hypertens Rep,2018

3. Metabolic Syndrome and clinical outcomes in patients infected with COVID-19: Does age, sex and race of the patient with Metabolic Syndrome matter?;Lohia P;J Diabetes,2021

4. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5.

5. Kelly West Lecture 1991. Challenges in diabetes epidemiology–from West to the rest;Zimmet PZ;Diabetes Care,1992

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3